한빛사논문
- 조회407
Lee, Kyong Joo M.D. & Ph.Da; Park, Se Woo M.D. & Ph.Da; Park, Da Hae BSNa; Cha, Hye Won BSNa; Choi, Anaa; Koh, Dong Hee M.D. & Ph.Da; Lee, Jin M.D. & Ph.Da; Lee, Jung Min M.Db; Park, Chan Hyuk M.D. & Ph.Dc
*Corresponding Author : S W. Park
Abstract
Background: Gallstones are a well-known risk factor for acute cholecystitis. However, their role as a risk factor for gallbladder perforation (GBP) remains unclear. Therefore, this study aimed to determine the effect of gallstones on the development of GBP.
Materials and methods: This large-scale retrospective cohort study enrolled consecutive patients who underwent cholecystectomy for acute cholecystitis. The primary endpoint was the role of gallstones as a risk factor for developing GBP. Secondary endpoints included the clinical characteristics of GBP, other risk factors for GBP, differences in clinical outcomes between patients with acalculous cholecystitis (AC) and calculous cholecystitis (CC), and the influence of cholecystectomy timing.
Results: A total of 4497 patients were included in this study. The incidence of GBP was significantly higher in the AC group compared to the CC group (5.6% vs. 1.0%, P<0.001). However, there were no differences in ICU admission and hospital stay durations. The incidence of overall complications was significantly higher in the AC group than in the CC group (2.2% vs. 1.0%, P<0.001). Patients with AC had a higher risk of developing GBP than those with CC (odds ratio, 5.00; 95% confidence interval, 2.94-8.33). In addition, older age (≥60 y), male sex, comorbidities, poor performance status, and concomitant acute cholangitis were associated with the development of GBP. Furthermore, the incidence of GBP was significantly higher in the delayed cholecystectomy group than in the early cholecystectomy group (2.0% vs. 0.9%, P<0.001).
Conclusions: AC is a significant risk factor for GBP. Furthermore, early cholecystectomy can significantly reduce GBP-related morbidity and mortality.
논문정보
- Research article
- 2023년 12월 (BRIC 등록일 2023-12-12)
- 국내 연구진
- 의약학 > 종양의학
댓글 작성 로그인
팝업 닫기관련 링크
연구자 키워드
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기
